SRX Global buys senior secured debt in CERo Therapeutics Holdings - CERO News | RalliesSRX Global buys senior secured debt in CERo Therapeutics Holdings
C
CERO• SRX Global buys senior secured debt in CERo Therapeutics Holdings
- SRX Global bought senior secured debt in CERo Therapeutics Holdings to fund development of its engineered T-cell therapy program.
- Proceeds are expected to accelerate CERo’s lead candidate, CER-1236, in the Phase 1 CERTAIN-T trial for hematologic cancers.
- CERo has treated six patients; the latest higher-dose cohort reported no dose-limiting toxicities during the assessment period.
AZUL
•